Radioimmunoassay for mouse nerve growth factor (NGF). Effects of thyroxine administration on tissue NGF levels.
A sensitive and specific radioimmunoassay (RIA) has been developed for beta-nerve growth factor (NGF) purified from the submaxillary gland of the adult male mouse. The RIA is sensitive to 13 pg/assay tube with an intra-assay coefficient of variation of 7% and an interassay coefficient of variation of 11.8%. Of the substances tested for immunological cross-reactivity in the RIA, only mouse epidermal growth factor caused significant displacement of the radiolabeled ligand; 11% at a dose of 10 microgram/ml. Mouse tissue extracts diluted out parallel to the standard curve. The effects of altered thyroid function on tissue NGF concentration in adult male mice were studied using the RIA. Thyroxine administration (25 microgram T4 i.p. daily for 12 days) caused significant increases in submaxilllary gland and liver NGF content and concentration (P less than 0.001) compared to controls but had no significant effect on heart and kidney NGF levels. Propylthiouracil treatment (0.05% PTU in the drinking water for 21 days) led to a marked increase in thyroid gland weight (550% of control) but had no significant effect on NGF concentration in any of the organs studied with the exception of kidney where a 75% reduction in NGF concentration was observed. These studies indicate that thyroid hormones increase NGF content and concentration in the submaxillary gland and liver of adult male mice and are suggestive of increased NGF synthesis. Thyroid hormones may therefore play an important regulatory role in NGF metabolism in peripheral tissues of the adult mouse.
D000818:Animals; D003429:Cross Reactions; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D009414:Nerve Growth Factors / Q000032:analysis / Q000378:metabolism*; D009928:Organ Specificity; D011441:Propylthiouracil / Q000494:pharmacology; D011863:Radioimmunoassay / Q000379:methods; D013363:Submandibular Gland / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D013961:Thyroid Gland / Q000187:drug effects / Q000378:metabolism; D013974:Thyroxine / Q000494:pharmacology*
D009414:Nerve Growth Factors; D011441:Propylthiouracil; D013974:Thyroxine